The Novel Use of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) to Reverse Cerebral Amyloidosis and Cognitive Impairment in Alzheimer’s Disease Mouse Models: Insights from the Investigation of Rheumatoid Arthritis as a Negative Risk Factor for Alzheimer’s Disease
For many years, it has been known that Rheumatoid arthritis (RA) is a negative risk factor for the development of Alzheimer’s disease (AD). It has been commonly assumed that RA patients’ usage of non-steroidal anti-inflammatory drugs (NSAIDs) have helped prevent the onset and progression of AD patho...
Main Author: | Boyd, Timothy David |
---|---|
Format: | Others |
Published: |
Scholar Commons
2010
|
Subjects: | |
Online Access: | http://scholarcommons.usf.edu/etd/3571 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=4753&context=etd |
Similar Items
-
Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics
by: Lorenzo Gaetani, et al.
Published: (2021-07-01) -
Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
by: Silvia Fossati, et al.
Published: (2019-12-01) -
Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
by: Hong-Wei Sun, et al.
Published: (2021-02-01) -
Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
by: Kuo-Hsuan Chang, et al.
Published: (2019-09-01) -
Exacerbated CSF abnormalities in younger patients with Alzheimer's disease
by: Julien Dumurgier, et al.
Published: (2013-06-01)